The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...
He’d take a private boat tour of the island, do a bit of snorkeling, and then top it all off with stem cell treatment. The ...
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
Over the past 18 years, the MSCRF has allocated $208 million in funding to 600 research projects and 41 different entities within the state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback